Protagenic Therapeutics Inc (NASDAQ: PTIX) is 0.29% higher on its value in year-to-date trading and has touched a low of $2.35 and a high of $26.18 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PTIX stock was last observed hovering at around $11.10 in the last trading session, with the day’s loss setting it -4.22%.
Currently trading at $6.88, the stock is 84.01% and 82.83% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.88 million and changing -38.02% at the moment leaves the stock 2.90% off its SMA200. PTIX registered -64.63% loss for a year compared to 6-month loss of -28.85%.
The stock witnessed a 135.13% gain in the last 1 month and extending the period to 3 months gives it a 94.24%, and is 96.01% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 43.59% over the week and 23.45% over the month.
Protagenic Therapeutics Inc (PTIX) has around 3 employees, a market worth around $4.05M and $0.00M in sales. Distance from 52-week low is 192.77% and -73.72% from its 52-week high.
.
Protagenic Therapeutics Inc (PTIX) Top Institutional Holders
The shares outstanding are 0.54M, and float is at 0.51M with Short Float at 3.32%.
Protagenic Therapeutics Inc (PTIX) Insider Activity
#####
